Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterising the Genomic and Phenotypic Changes That Define Injury and Repair in the Context of Early Carcinogenesis in the Human Oesophagus.

NCT06820151 is registered in ClinicalTrials.gov with The Wellcome Sanger Institute as lead sponsor.

NCT NCT06820151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06820151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterising the Genomic and Phenotypic Changes That Define Injury and Repair in the Context of Early Carcinogenesis in the Human Oesophagus.
Lead sponsor
The Wellcome Sanger Institute
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2022
Completion date
April 29, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perforations to the oesophagus